181 related articles for article (PubMed ID: 31492037)
1. In Vivo Anti-Tumor Effects of Citral on 4T1 Breast Cancer Cells via Induction of Apoptosis and Downregulation of Aldehyde Dehydrogenase Activity.
Nigjeh SE; Yeap SK; Nordin N; Rahman H; Rosli R
Molecules; 2019 Sep; 24(18):. PubMed ID: 31492037
[TBL] [Abstract][Full Text] [Related]
2. Antitumor and Anti-Metastatic Effects of Citral-Loaded Nanostructured Lipid Carrier in 4T1-Induced Breast Cancer Mouse Model.
Nordin N; Yeap SK; Rahman HS; Zamberi NR; Mohamad NE; Abu N; Masarudin MJ; Abdullah R; Alitheen NB
Molecules; 2020 Jun; 25(11):. PubMed ID: 32526880
[TBL] [Abstract][Full Text] [Related]
3. Citral reduces breast tumor growth by inhibiting the cancer stem cell marker ALDH1A3.
Thomas ML; de Antueno R; Coyle KM; Sultan M; Cruickshank BM; Giacomantonio MA; Giacomantonio CA; Duncan R; Marcato P
Mol Oncol; 2016 Nov; 10(9):1485-1496. PubMed ID: 27592281
[TBL] [Abstract][Full Text] [Related]
4. Citral induced apoptosis in MDA-MB-231 spheroid cells.
Nigjeh SE; Yeap SK; Nordin N; Kamalideghan B; Ky H; Rosli R
BMC Complement Altern Med; 2018 Feb; 18(1):56. PubMed ID: 29433490
[TBL] [Abstract][Full Text] [Related]
5. In vitro cytotoxicity and anticancer effects of citral nanostructured lipid carrier on MDA MBA-231 human breast cancer cells.
Nordin N; Yeap SK; Rahman HS; Zamberi NR; Abu N; Mohamad NE; How CW; Masarudin MJ; Abdullah R; Alitheen NB
Sci Rep; 2019 Feb; 9(1):1614. PubMed ID: 30733560
[TBL] [Abstract][Full Text] [Related]
6. High aldehyde dehydrogenase activity enhances stem cell features in breast cancer cells by activating hypoxia-inducible factor-2α.
Kim RJ; Park JR; Roh KJ; Choi AR; Kim SR; Kim PH; Yu JH; Lee JW; Ahn SH; Gong G; Hwang JW; Kang KS; Kong G; Sheen YY; Nam JS
Cancer Lett; 2013 Jun; 333(1):18-31. PubMed ID: 23174107
[TBL] [Abstract][Full Text] [Related]
7. Optimized Dosing Schedule Based on Circadian Dynamics of Mouse Breast Cancer Stem Cells Improves the Antitumor Effects of Aldehyde Dehydrogenase Inhibitor.
Matsunaga N; Ogino T; Hara Y; Tanaka T; Koyanagi S; Ohdo S
Cancer Res; 2018 Jul; 78(13):3698-3708. PubMed ID: 29735553
[TBL] [Abstract][Full Text] [Related]
8. Formulation, Characterization, and Antitumor Properties of Trans- and Cis-Citral in the 4T1 Breast Cancer Xenograft Mouse Model.
Zeng S; Kapur A; Patankar MS; Xiong MP
Pharm Res; 2015 Aug; 32(8):2548-58. PubMed ID: 25673043
[TBL] [Abstract][Full Text] [Related]
9. Targeting aberrant expression of Notch-1 in ALDH
Pal D; Kolluru V; Chandrasekaran B; Baby BV; Aman M; Suman S; Sirimulla S; Sanders MA; Alatassi H; Ankem MK; Damodaran C
Mol Carcinog; 2017 Mar; 56(3):1127-1136. PubMed ID: 27753148
[TBL] [Abstract][Full Text] [Related]
10. Doxorubicin-enriched, ALDH(br) mouse breast cancer stem cells are treatable to oncolytic herpes simplex virus type 1.
Zhuang X; Zhang W; Chen Y; Han X; Li J; Zhang Y; Zhang Y; Zhang S; Liu B
BMC Cancer; 2012 Nov; 12():549. PubMed ID: 23176143
[TBL] [Abstract][Full Text] [Related]
11. Murine breast carcinoma 4T1 cells are more sensitive to atranorin than normal epithelial NMuMG cells in vitro: Anticancer and hepatoprotective effects of atranorin in vivo.
Solár P; Hrčková G; Koptašíková L; Velebný S; Solárová Z; Bačkor M
Chem Biol Interact; 2016 Apr; 250():27-37. PubMed ID: 26969521
[TBL] [Abstract][Full Text] [Related]
12. Antitumor and antimetastatic activities of chloroquine diphosphate in a murine model of breast cancer.
Jiang PD; Zhao YL; Deng XQ; Mao YQ; Shi W; Tang QQ; Li ZG; Zheng YZ; Yang SY; Wei YQ
Biomed Pharmacother; 2010 Nov; 64(9):609-14. PubMed ID: 20888174
[TBL] [Abstract][Full Text] [Related]
13. Subchronic toxicity, immunoregulation and anti-breast tumor effect of Nordamnacantal, an anthraquinone extracted from the stems of Morinda citrifolia L.
Abu N; Zamberi NR; Yeap SK; Nordin N; Mohamad NE; Romli MF; Rasol NE; Subramani T; Ismail NH; Alitheen NB
BMC Complement Altern Med; 2018 Jan; 18(1):31. PubMed ID: 29374471
[TBL] [Abstract][Full Text] [Related]
14. Yulangsan polysaccharide inhibits 4T1 breast cancer cell proliferation and induces apoptosis in vitro and in vivo.
Qin N; Lu S; Chen N; Chen C; Xie Q; Wei X; Ye F; He J; Li Y; Chen L; Jiang L; Lu X; Yuan Y; Li J; Jiao Y; Huang R
Int J Biol Macromol; 2019 Jan; 121():971-980. PubMed ID: 30340007
[TBL] [Abstract][Full Text] [Related]
15. Interferon-gamma inhibits aldehyde dehydrogenasebright cancer stem cells in the 4T1 mouse model of breast cancer.
Zhuang X; Shi G; Hu X; Wang H; Sun W; Wu Y
Chin Med J (Engl); 2021 Dec; 135(2):194-204. PubMed ID: 34890380
[TBL] [Abstract][Full Text] [Related]
16. The metabolism of 3,7-dimethyl-2,6-octadienal (citral) in rat hepatic mitochondrial and cytosolic fractions. Interactions with aldehyde and alcohol dehydrogenases.
Boyer CS; Petersen DR
Drug Metab Dispos; 1991; 19(1):81-6. PubMed ID: 1673427
[TBL] [Abstract][Full Text] [Related]
17. [Study on mechanism of inhibiting proliferation of head and neck cancer cells by citral, active ingredient of lemon essential oil].
Chen L; Zhang YJ; Qin HW; Hu WJ; Liu YJ; Xiao GS; DU HH; Yang DL
Zhongguo Zhong Yao Za Zhi; 2024 May; 49(9):2364-2375. PubMed ID: 38812137
[TBL] [Abstract][Full Text] [Related]
18. Crosstalk between aldehyde dehydrogenase-1 and chemoresistance in breast cancer: Insights into the role of vitamin D3.
Attia YM; Hammam OA; Ammar RA; Mansour MT; Elmazar MM
Life Sci; 2020 Jul; 253():117733. PubMed ID: 32360127
[TBL] [Abstract][Full Text] [Related]
19. Galiellalactone inhibits stem cell-like ALDH-positive prostate cancer cells.
Hellsten R; Johansson M; Dahlman A; Sterner O; Bjartell A
PLoS One; 2011; 6(7):e22118. PubMed ID: 21779382
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of aldehyde dehydrogenase (ALDH) activity reduces chemotherapy and radiation resistance of stem-like ALDHhiCD44⁺ human breast cancer cells.
Croker AK; Allan AL
Breast Cancer Res Treat; 2012 May; 133(1):75-87. PubMed ID: 21818590
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
